Award Year / Program / Phase:1985 / SBIR / Phase I
Agency:HHS
Principal Investigator:Theodore g. gabig , PRINCIPAL INVESTIGATOR
Award Amount:$50,000.00
Abstract:
We propose to develop a standardized kit of monoclonal antibody (moab) conjugated with a novel biological catalyst toxin to be used for the ex vivo elimination of neoplastic cells from human autologous bone marrow grafts. the technical objectives are to prepare a toxin-conjugated murine moab that… More